Eric Van Cutsem
机构：Universitair Ziekenhuis Leuven, KU Leuven · ORCID：0000-0002-6372-1230
发表论文 1840 篇 · 总被引 178232 次 · h-index 177
代表论文
- CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma (2025 · Cancers · 被引 6)
- Impact of RAS / BRAF V600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair–Deficient/Microsatellite Instability Colorectal Cancers (2025 · Clinical Cancer Research · 被引 4)
- Amivantamab Monotherapy in Chemorefractory RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study (2026 · Journal of Clinical Oncology · 被引 2)
- BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026 · Cancer Research Communications · 被引 2)
- Antibody–drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation (2026 · ESMO Open)
- Table 4 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)